Supernus Pharmaceuticals, Inc.

COMMONWEALTH EQUITY SERVICES, LLC SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

10,376

Value ($000)

516

Weight

0.0%

2020 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	516	0.0%	10,376	12/31/2025
2025 Q3	10/22/2025	405	0.0%	8,466	9/30/2025
2025 Q2	8/6/2025	306	0.0%	9,695	6/30/2025
2025 Q1	5/9/2025	314	0.0%	9,586	3/31/2025
2024 Q4	2/10/2025	354	0.0%	9,796	12/31/2024
2024 Q3	10/18/2024	320	0.0%	10,250	9/30/2024
2024 Q2	7/31/2024	273	0.0%	10,195	6/30/2024
2024 Q1	4/29/2024	336	0.0%	9,845	3/31/2024
2023 Q4	2/6/2024	290	0.0%	10,030	12/31/2023
2023 Q3	10/23/2023	266	0.0%	9,648	9/30/2023
2023 Q2	8/10/2023	284	0.0%	9,451	6/30/2023
2023 Q1	5/11/2023	322	0.0%	8,901	3/31/2023
2022 Q4	2/7/2023	310	0.0%	8,701	12/31/2022
2022 Q3	11/14/2022	345	0.0%	10,219	9/30/2022
2022 Q2	7/19/2022	306	0.0%	10,604	6/30/2022
2022 Q1	5/4/2022	336	0.0%	10,423	3/31/2022
2021 Q4	1/31/2022	312	0.0%	10,709	12/31/2021
2021 Q3	10/29/2021	303	0.0%	11,380	9/30/2021
2021 Q2	8/11/2021	306	0.0%	9,940	6/30/2021
2021 Q1	5/4/2021	250	0.0%	9,578	3/31/2021
2020 Q4	2/11/2021	240	0.0%	9,578	12/31/2020